Other Litigation and Disputes

This is FindLaw’s collection of Other Litigation and Dispute articles, part of the Litigation and Disputes section of the Corporate Counsel Center. Here you’ll find valuable information on Sarbanes-Oxley Whistleblower Protection extended by the Supreme Court of the United States, an informative piece on understanding your ethical obligations as in-house counsel if you represent an employee, as well as the company, and frequently asked litigation questions. You’ll also be able to learn the advantages that litigation finance offers to both corporate clients and their lawyers. Law articles in this archive are predominantly written by lawyers for a professional audience seeking business solutions to legal issues. Start your free research with FindLaw.

Litigation and Disputes

Other Litigation and Disputes Articles

FAQ’S About Hiring a Personal Injury Law Firm

Talking with an attorney is the first step in determining whether you should seek legal recourse for injuries you (or a family member) have suffered. In an initial consultation, the attorney will seek answers to three key questions: Is there time to ...
Read More »
FCC and Congress Look for New Frequency Bands for Expanded WiFi Use

Recent interest in unlicensed wireless operations using the 802.11 standard, often called "WiFi," has led both the FCC and Congress to identify additional spectrum where WiFi operations might be possible. The FCC recently issued a Notice of Inquiry ...
Read More »
FCC Decisions on VoIP Classification Will Affect the Future of the Service

Voice over Internet Protocol ("VoIP") is arguably one of the most important recent developments in telecommunications, yet is virtually ignored by current federal and state regulations applicable to traditional telephone service. However, the ...
Read More »
FCC Extends Sunset of “Established Business Relationship” Exemption For Unsolicited Facsimile Ads Under TCPA

The Telephone Consumer Protection Act ("TCPA") provides generally that it is unlawful for any person to "use any telephone facsimile machine, computer, or other device to send an unsolicited advertisement to a telephone facsimile machine." 47 ...
Read More »
FCC Prohibits Fax Advertising Without Signed Written Consent From Recipient

On July 25, 2003, the Federal Communications Commission ("FCC") published revisions to its Rules and Regulations implementing the Telephone Consumer Protection Act (the "TCPA Rules"). With a few exceptions, the final rules will take effect on August ...
Read More »
FCC Seeks Comments In Ultra-Wideband Proceeding Alert

Initial comments are due on September 12, 2000 for the Federal Communications Commission’s Notice of Proposed Rule Making concerning ultra-wideband (UWB) devices. In this NPRM, the FCC seeks comments on a host of issues, including which types of UWB ...
Read More »
FDA Issues Guidance for New Strategy on Reuse of Single-Use Medical Devices: “Enforcement Priorities for Single-Use Devices Reprocessed by Third Parties and Hospitals”

On August 14, 2000, the Food and Drug Administration ("FDA")'s Center for Devices and Radiological Health issued "Enforcement Priorities for Single-Use Devices Reprocessed by Third Parties and Hospitals," a final guidance on the reuse of medical ...
Read More »
FDA to Regulate the Reprocessing of Disposable Medical Devices by Hospitals

The Food and Drug Administration (FDA) recently issued draft guidance documents outlining how, for the first time, it will comprehensively regulate hospitals that reprocess and reuse medical devices that are labeled as disposable or “single-use ...
Read More »
FDA: Too Little Too Late

Claims resulting from latex exposure in the workplace continue to crowd the court dockets at epidemic levels. Injured workers have filed workers' compensation claims and claims against the manufacturers, distributors and suppliers of health care ...
Read More »
FDAMA Provision Restricting Dissemination of “Off-Label Information” Held Unconstitutional

In July 1999, the U.S. District Court for the District of Columbia issued the third in a series of decisions in Washington Legal Foundation v. Shalala. The decision further scales back the ability of the Food and Drug Administration (FDA) to ...
Read More »